← Eichor
Study identifier: NCT06006637 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Condition: Autism Spectrum Disorder  ·  Sponsor: State University of New York - Upstate Medical University

PhaseNA
Planned participants80
Who can joinAll sexes, 2 Years to 8 Years
Healthy volunteersNo

About this study

This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

This description comes directly from the study's public registry record.

Talk to the study team

William E Sullivan, PhD  ·  315-464-3932  ·  sullivaw@upstate.edu

Henry S Roane, PhD  ·  315-464-3555  ·  roaneh@upstate.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Mt. Sinai Medical CenterNew York, New York, United StatesRecruiting
Golisano Center for Special NeedsSyracuse, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06006637